ANNUAL REPORT
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories Limited) has submitted its 31st Annual Report for FY 2024-25 along with the AGM notice. The 31st AGM is scheduled for Monday, 29th September 2025 at 09:30 AM at the registered office in Sohna, Haryana. E-voting cut-off date is 22nd September 2025 and the e-voting window runs from 26th to 28th September 2025. Ordinary business includes adoption of audited FY25 financial statements and re-appointment of Managing Director Mr. Peeyush Kumar Aggarwal, who retires by rotation. Special business includes (a) approval of related party transactions with a total cap of Rs. 1,280 lakhs for FY 2025-26, covering unsecured loans from the MD (up to Rs. 50 lakhs), Omkam Global Capital (up to Rs. 500 lakhs; Rs. 663.78 lakhs already outstanding as of 31/03/25), Omkam Developers (up to Rs. 500 lakhs), MPS Informatics (up to Rs. 200 lakhs), and remuneration caps of Rs. 15 lakhs each for the CFO and Company Secretary; and (b) appointment of M/s Kundan Agrawal & Associates as Secretarial Auditor for 5 consecutive years (FY 2025-26 to FY 2029-30).
Largely routine AGM filings, but shareholders should note the sizable related party transactions cap of Rs. 1,280 lakhs—predominantly with entities linked to the Managing Director Mr. Peeyush Kumar Aggarwal—which is a key governance consideration. Approval of these items requires shareholder voting via remote e-voting or at the AGM.